Humana Inc: Form 10-K for the period ended Dec 31, 2018
Filed with the SEC on Feb 21, 2019 and accepted by EDGAR at Feb 21, 2019, 16:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-10-01 to 2018-12-31 | $14.17bn | us-gaap:Revenues |
| Revenue | 12 months2018-01-01 to 2018-12-31 | $56.91bn | us-gaap:Revenues |
| Selling, general and administrative | 12 months2018-01-01 to 2018-12-31 | $7.53bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2018-01-01 to 2018-12-31 | $3.10bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $218.0m | us-gaap:InterestExpense |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $391.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-10-01 to 2018-12-31 | $355.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2018-01-01 to 2018-12-31 | $1.68bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-10-01 to 2018-12-31 | $2.58 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | $12.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-10-01 to 2018-12-31 | $2.60 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2018-01-01 to 2018-12-31 | $12.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-01-01 to 2018-12-31 | 138,403,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | $2.17bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $612.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2018-01-01 to 2018-12-31 | $265.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2018-01-01 to 2018-12-31 | $1.09bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-12-31 | $2.34bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $16.95bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $25.41bn | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $10.08bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $15.25bn | us-gaap:Liabilities |
| Long-term debt | At period end2018-12-31 | $4.38bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2018-12-31 | $1.69bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-12-31 | $10.16bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000049071-19-000023. Last ingested by Listed: Nov 12, 2026, 20:28 ET. Listed shows no prices and gives no investment advice.